精進電動(688280.SH):碳化硅控制器已經獲得德國曼恩和瑞典斯堪尼亞的定點,會單獨出售
格隆匯6月9日丨有投資者向精進電動(688280.SH)提問,“公司為何不單獨出售電控產品,是因為小鵬G3事件影響銷售還是公司策略不單獨售賣?公司有無在關聯行業拓展的計劃,比如光伏逆變器”
精進電動回覆稱,首先公司之前澄清過多次,小鵬召回的控制器不是精進的產品,召回事件也與精進電動沒有任何關係。公司的碳化硅控制器已經獲得德國曼恩和瑞典斯堪尼亞的定點,會單獨出售。該產品在開發過程中,預計2024年量產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.